Metastasis regulation by PPARD expression in cancer cells

Xiangsheng Zuo, Weiguo Xu, Min Xu, Rui Tian, Micheline J. Moussalli, Fei Mao, Xiaofeng Zheng, Jing Wang, Jeffrey S. Morris, Mihai Gagea, Cathy Eng, Scott Kopetz, Dipen M. Maru, Asif Rashid, Russell Broaddus, Daoyan Wei, Mien Chie Hung, Anil K. Sood, Imad Shureiqi

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Abstract

Peroxisome proliferator-activated receptor-δ (PPARD) is upregulated in many major human cancers, but the role that its expression in cancer cells has in metastasis remains poorly understood. Here, we show that specific PPARD downregulation or genetic deletion of PPARD in cancer cells significantly repressed metastasis in various cancer models in vivo. Mechanistically, PPARD promoted angiogenesis via interleukin 8 in vivo and in vitro. Analysis of transcriptome profiling of HCT116 colon cancer cells with or without genetic deletion of PPARD and gene expression patterns in The Cancer Genome Atlas colorectal adenocarcinoma database identified novel pro-metastatic genes (GJA1, VIM, SPARC, STC1, SNCG) as PPARD targets. PPARD expression in cancer cells drastically affected epithelial-mesenchymal transition, migration, and invasion, further underscoring its necessity for metastasis. Clinically, high PPARD expression in various major human cancers (e.g., colorectal, lung, breast) was associated with significantly reduced metastasis-free survival. Our results demonstrate that PPARD, a druggable protein, is an important molecular target in metastatic cancer.

Original languageEnglish (US)
Article numbere91419
JournalJournal of Clinical Investigation
Volume2
Issue number1
DOIs
StatePublished - Jan 12 2017

ASJC Scopus subject areas

  • General Medicine

MD Anderson CCSG core facilities

  • Cytogenetics and Cell Authentication Core

Fingerprint

Dive into the research topics of 'Metastasis regulation by PPARD expression in cancer cells'. Together they form a unique fingerprint.

Cite this